Amy N. Luckenbaugh, MD, FACS
Medical Degree: State University of New York at Buffalo
Residency: University of Michigan
Fellowship: Vanderbilt University Medical Center
Clinical Interests: Bladder Cancer, Kidney Cancer, Prostate Cancer, Testis Cancer, Urologic Cancer
Dr. Luckenbaugh is a high-volume surgeon whose clinical focus centers on the comprehensive care of patients with urologic malignancies. She holds the Gail and Rich Kraemer Bladder Cancer Directorship. Institutionally, she is the perioperative director for urology, and the quality and safety officer for the urology department. Luckenbaugh is the former chair of Women in Urologic Oncology and the Past-President for the Society of Women in Urology.
Dr. Luckenbaugh Faculty Bio
About Your Prostate Cancer Diagnosis
Active Clinical Trials
Bond 003
To evaluate the activity of intravesical (IVE) administration of CG0070 in patients with tissue pathology confirmed non-muscular invasive bladder cancer (NMIBC) who have Bacillus-Calmette-Guerin (BCG) unresponsive disease, with either carcinoma in situ with or without Ta/T1 disease
TAR-200
A Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus Calmette-Guérin (BCG) (SunRISe-5)